Aug 24, 2026 07:06AM
Aug 24, 2026 07:00AM
Aug 10, 2026 06:34AM
Jun 10, 2026 07:55AM
May 20, 2026 07:00AM
May 20, 2026 07:00AM
Apr 24, 2026 08:01AM Scinai Immunotherapeutics raises $2.61 million in private placement
Apr 24, 2026 08:00AM
Apr 6, 2026 07:01AM
Apr 6, 2026 07:00AM
Apr 1, 2026 07:35AM
Mar 19, 2026 07:50AM
Mar 2, 2026 09:20AM
Mar 2, 2026 09:20AM Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept
Feb 25, 2026 08:12AM
Feb 25, 2026 08:11AM
Feb 17, 2026 07:00AM
Jan 7, 2026 07:00AM
Dec 2, 2025 08:55AM
Dec 2, 2025 08:50AM
Oct 6, 2025 07:31AM Scinai receives $246,000 Israel grant for manufacturing expansion
Oct 6, 2025 07:30AM
Sep 2, 2025 07:30AM
Jul 29, 2025 07:16AM
Jul 29, 2025 07:15AM
Jun 26, 2025 07:37AM
Jun 12, 2025 08:00AM
Jun 5, 2025 09:01AM Scinai Immunotherapeutics (SCNI) Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.
Jun 5, 2025 09:00AM
May 30, 2025 07:00AM
May 7, 2025 04:01PM
May 1, 2025 07:00AM
Mar 27, 2025 09:27AM
Mar 27, 2025 09:25AM
Mar 17, 2025 07:00AM Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025
Mar 5, 2025 07:32AM
Mar 5, 2025 07:30AM
Jan 6, 2025 07:31AM
Dec 16, 2024 09:25AM
Dec 5, 2024 08:25AM
Nov 27, 2024 08:00AM
Nov 22, 2024 07:15AM Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million
Oct 31, 2024 06:59AM
Sep 16, 2024 07:00AM
Aug 29, 2024 06:32AM
Aug 29, 2024 06:31AM
Aug 21, 2024 08:45AM
Aug 15, 2024 07:00AM
Aug 13, 2024 07:55AM Scinai (SCNI) Announces Signing of Loan Restructuring Agreement with European Investment Bank; Converting Approximately $29 million of Debt to Preferred Equity Convertible into 19.5% Common Equity
Aug 13, 2024 07:00AM

1,184,427 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All